NR1H4 and atherosclerosis: Tauro-β-muricholic acid (TβMCA), known to contribute to the development of atherosclerosis through farnesoid X receptor (FXR) antagonism (46, –, 48), had overall higher relative abundances in mice under IHC conditions (Fig. S4B).